Atypical Lymphadenopathies of the Head and Neck

References

• Greenfield S., Jordan C. The clinical investigation of lymphad enopathy in primary care practice. JAMA 1978; 240: 1388
   Web of Science ®Google Scholar
• Dorfman R. F., Warnke R. Lymphadenopathy simulating the malignant lymphomas. Hum. Pathol. 1974; 5: 519
   PubMed Web of Science ®Google Scholar
• Schroer K. R., Franssila K. O. Atypical hyperplasia of lymph nodes. A follow-up study. Cancer, (Philadelphia) 1979; 44: 1155
   Google Scholar
• MacGavran M. H., Spady H. A. Eosinophilic granuloma of bone. A study of 28 cases. J. Bone J. Surg. 1960; 42A: 919
   Google Scholar
• Newton W. A., Hamoudi A. B. Histiocytosis: histologic classification with clinical correlation. Perspectives in Pediatric Pathology, H. S. Rosenberg, R. P. Bolande. Year Book, Medical Publishing, Chicago 1973; Vol. I: 251
   Google Scholar
• Vogel J. M., Vogel P. Idiopathic histiocytosis: a discussion of eosinophilic granuloma, HandSchüller-Christian and Letterer-Siwe syndromes. Semin. Hematol. 1972; 9: 349
   PubMedGoogle Scholar
• Tos M. A survey of Hand-Schüller-Christian disease in otolaryngology. Acta Oto Laryngol. 1966; 62: 217
   PubMedGoogle Scholar
• Enriquez P., Dahlin D. C., Hayles A. B., Henderson E. D. Histiocytosis X: a clinical study. Mayo Clin. Proc. 1967; 42: 88
   PubMedGoogle Scholar
• Moskow R., Levine L. J., Marin A. Multifocal eosinophilic or both granuloma simulating periodontal disease. N. Y. State Dent. J. 1971; 37: 607
   Google Scholar
• Lucaya J. Histiocytosis X. Am. J. Dis. Child. 1971; 121: 289
   PubMedGoogle Scholar
• Daneshbod K., Kissane J. M. Histiocytosis. The prognosis of polyostotic eosinophilic granuloma. Am. J. Clin. Pathol. 1976; 65: 601
   Google Scholar
• Daneshbod K., Kissane J. M. Idiopathic differentiated histiocytosis. Am. J. Clin. Pathol. 1978; 70: 381
   PubMedGoogle Scholar
• Nezelof C., Frileux-Herbet F., Cronier-Sachot J. Disseminated histiocytosis X. Analysis of prognostic factors based on a retrospective study of 50 cases. Cancer (Philadelphia) 1979; 44: 1824
   PubMed Web of Science ®Google Scholar
• Lahey M. E. Histiocytosis X: a analysis of prognostic factors. J. Pediatr. 1975; 87: 184
   PubMed Web of Science ®Google Scholar
• Starling K. A., Donaldson M. H., Haggard M. E., Vietti T. J., Sutow W. W. Therapy of histiocytosis X with vincristine, vinblastine, and cyclophosphamide, the Southwest Cancer Chemotherapy Study Group. Am. J. Dis. Child. 1972; 123: 105
   PubMedGoogle Scholar
• Jones B., King F., Chevalier L., Forman E. N., Rausen A., Koch K., Desposito F., Maurer H., Jacquillat C., Degan T. J., Pluss H., Desforgs J., Patterson R. B., Glidewell O., Holland J. F. Chemotherapy of reticuloendotheliosis, comparison of methotrexate plus prednisone vs. vincristine plus prednisone. Cancer (Philadelphia) 1975; 34: 1011
   Google Scholar
• Lahey M. E. Histiocytosis X: comparison of three treatment regimens. J. Pediatr. 1975; 87: 179
   PubMed Web of Science ®Google Scholar
• Williams J. W., Dorfman R. F. Lymphadenopathy as the initial manifestation of histiocytosis X. Am. J. Surg. Pathol. 1979; 3: 405
   PubMed Web of Science ®Google Scholar
• Warnke R. A., Kim H., Dorfman R. F. Malignant histiocytosis (histiocytic medullary reticulosis). I. Clinicopathologic study of 29 cases. Cancer (Philadelphia) 1975; 35: 215
   PubMed Web of Science ®Google Scholar
• Miller D. R. Familial reticuloendotheliosis: concurrence of disease in five siblings. Pediatrics 1966; 38: 986
   PubMed Web of Science ®Google Scholar
• Nelson P., Santamaria A., Olsen R. L., Nayak N. C. Generalized lymphohistiocytic infiltration. A familial disease not previously described and different from Letterer-Siwe and Chediak-Higashi syndrome. Pediatrics 1961; 27: 931
   Google Scholar
• Bell R. J. M., Brafield A. J. E., Barnes N. D., France N. E. Familial hemophagocytic reticulosis. Arch. Dis. Child. 1968; 43: 601
   Google Scholar
• Koto A., Morecki R., Santorneou M. Congenital hemophagocytic reticulosis. Am. J. Clin. Pathol. 1976; 65: 495
   Google Scholar
• Risdall R. J., McKenna R. W., Nesbit M. E., Krivit W., Balfour H. H., Simmons R. L., Brunning R. D. Virus associated hemophagocytic syndrome. A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer (Philadelphia) 1979; 44: 993
   PubMed Web of Science ®Google Scholar
• Cederbaum S. D., Niwayama G., Stiehm E. R., Neerhout R. C., Ammann A. J., Berman W. Combined immunodeficiency presenting as the Letterer-Siwe syndrome. J. Pediatr. 1974; 85: 466
   PubMed Web of Science ®Google Scholar
• Ochs H. D., Davis S. D., Mickelson E., Lerner K. G., Wedgewood R. S. Combined immunodeficiency and reticuloendotheliosis. J. Pediatr. 1974; 85: 463
   PubMed Web of Science ®Google Scholar
• Rosai J., Dorfman R. F. Sinus histiocytosis with massive lymphadenopathy: a pseudolymphomatous benign disorder. Analysis of 34 casesd. Cancer (Philadelphia) 1972; 30: 1174
   PubMedGoogle Scholar
• Juberg R. C., Kloepter H. W., Oberman H. A. Genetic determination of acute disseminated histiocytosis X (Letterer-Siwe syndrome). Pediatrics 1970; 45: 753
   Google Scholar
• Ahnquist G., Holyoke J. B. Congenital Letterer-Siwe disease (reticuloendotheliosis) in a term stillborn infant. J. Pediatr. 1960; 57: 897
   PubMed Web of Science ®Google Scholar
• Claman H. N., Suva H. V., Githens H. H., Hathaway W. E. Histiocytic reaction in dysgammaglobulinemia and congenital rubella. Pediatrics 1970; 46: 89
   PubMed Web of Science ®Google Scholar
• Leikins S., Puruganan G., Frankel A., Steerman R., Chandra R. Immunologic parameters in histiocytosis X. Cancer (Philadelphia) 1973; 32: 796
   Google Scholar
• Nezelof C., Basset F., Rousseau M. F. Histiocytosis X. Histiogenic evidence for a Langerhans cell origin. Biomedicine 1973; 18: 365
   PubMedGoogle Scholar
• Jimbow K., Sato S., Kukita A. Cells containing Langerhans granules in human lymph nodes of dermatopathic lymphadenopathy. J. Invest. Dermatol. 1969; 53: 295
   PubMed Web of Science ®Google Scholar
• Sagebiel R. W., Reed T. H. Serial resconstruction of the characteristic granules of the Langerhans cell. J. Cell Biol. 1968; 36: 595
   PubMed Web of Science ®Google Scholar
• Vernon M. L., Fountain L., Krelo H. M., Horta-Barbose L., Fucillo D. A., Sever H. K. Birbeck granules (Langerhans cell granules) in human lymph nodes. Am. J. Clin. Pathol. 1973; 60: 771
   PubMedGoogle Scholar
• Hoshino T., Kukita A., Sato S. Cells containing Birbeck granules (Langerhans cell granules) in the human thymus. J. Electron Microsc. 1970; 19: 271
   PubMedGoogle Scholar
• Elema J. D., Poppema S. Infantile histiocytosis X (Letterer-Siwe disease). Investigations with enzyme histochemical and sheep erythrocyte rosetting technique. Cancer (Philadelphia) 1978; 42: 555
   Google Scholar
• Lieberman P. H., Jones C. R., Dargeon H. W. K., Begg C. F. A reappraisal of eosinophilic granuloma of bone, Hand-Schüller-Christian syndrome and Letterer-Siwe syndrome. Medicine (Baltimore) 1969; 48: 375
   PubMedGoogle Scholar
• Laymon C. W., Jackson R. Lipomelanotic reticulosis. Arch. Dermatol. 1955; 71: 303
   Google Scholar
• Rausch E., Kaiserling E., Goos M. Langerhan cells and interdigitating reticulum cells in the thymus dependent region in human dermatopathic lymphadenitis. Virchows Arch. B. 1977; 25: 327
   PubMedGoogle Scholar
• Rappaport H., Thomas L. B. Mycosis fungoides: the pathology of extra cutaneous involvement. Cancer (Philadelphia) 1974; 34: 1198
   PubMed Web of Science ®Google Scholar
• Scheffer E., Meijer C. J. L. M., VanVloten W. A. Dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides. Cancer (Philadelphia) 1980; 45: 137
   Google Scholar
• Lampert F., Lennert K. Sinus histiocytosis with massive lymphadenopathy: 15 new cases. Cancer (Philadelphia) 1976; 37: 783
   PubMed Web of Science ®Google Scholar
• Kessler E., Srulijes C., Toledo E., Shalit M. Sinus histiocytosis with massive lymphadenopathy and spinal epidural involvement. Cancer (Philadelphia) 1976; 38: 1614
   PubMed Web of Science ®Google Scholar
• Ramos C. B. Wide spread bone involvement in sinus histiocytosis. Arch. Pathol. Lab. Med. 1976; 100: 606
   Google Scholar
• Pickering L. K., Phelam E. Sinus histiocytosis. J. Pediatr. 1975; 86: 745
   Google Scholar
• Thawerani H., Sanchez R. L., Rosai J., Dorfman R. F. The cutaneous manifestations of sinus histiocytosis with massive lymphadenopathy. Arch. Dermatol. 1978; 114: 191
   Google Scholar
• Foucar E., Rosai J., Dorfman R. F. Sinus histiocytosis with massive lymphadenopathy. Ear, nose, and throat manifestations. Arch. Oto Laryngol. 1978; 104: 687
   PubMedGoogle Scholar
• Friendly D. S., Font R. L., Rao N. A. Orbital involvement in sinus histiocytosis. A report of 4 cases. Arch. Opthalmol. 1977; 95: 2006
   PubMedGoogle Scholar
• Bankaci M., Stool S. E., Morris R. F., Paradise J. L. Sinus histiocytosis with massive lymphadenopathy. Report of its occurrence in two siblings with retropharyngeal involvement in both. Ann. Otol. Rhinol. Laryngol. 1978; 87: 327
   Google Scholar
• Keller A. R., Hochholzer L., Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer (Philadelphia) 1972; 29: 670
   PubMed Web of Science ®Google Scholar
• Anagnustou D., Harrison C. V. Angiofollicular lymph node hyperplasia. J. Clin. Pathol. 1972; 25: 306
   Google Scholar
• Gaba A. H., Stein R. S., Sweet D. L., Valakojis D. Multicentric giant lymph node hyperplasia. Am. J. Clin. Pathol. 1978; 69: 86
   PubMed Web of Science ®Google Scholar
• Yu G. S. M., Carson J. W. Giant lymph node hyperplasia, plasma-cell type, of the mediastinum with peripheral neuropathy. Am. J. Clin. Pathol. 1976; 66: 46
   PubMed Web of Science ®Google Scholar
• van Vliet G., Vainsel M., Wolter R., Heiman R. Growth failure, refractory anemia, and hypergammaglobulinemia: their regression after removal of a mesenteric tumor with the features of giant lymph node hyperplasia, plasma-cell type. Acta Puediatr. Belg. 1978; 31: 41
   Google Scholar
• Weisenberger D. D., DeGowin R. L., Gibson D. P., Armitage J. O. Remission of giant lymph node hyperplasia with anemia after radiotherapy. Cancer (Philadelphia) 1979; 44: 457
   Google Scholar
• Nordstrom D. G., Tewfik H. H., Latourette H. B. Plasma cell giant lymph node hyperplasia responding to radiation therapy. Am. J. Roenfgenol. 1978; 130: 169
   Google Scholar
• Nosanchuk J. D., Schnitzer B. Follicular hyperplasia in the lymph nodes from patients with rheumatoid arthritis. Cancer (Philadelphia) 1969; 24: 343
   Web of Science ®Google Scholar
• Abell M. R. Lymph nodal hamartoma vs. thymic choristoma of pulmonary hilum. Arch. Puthol. 1957; 64: 584
   Google Scholar
• Tung K. S. K., McCormac L. J. Angiomatous lymphoid hamartoma. Report of five cases with the review of the literature. Cancer (Philadelphia) 1967; 20: 525
   PubMed Web of Science ®Google Scholar
• Blume R. S., Wolff S. The Chediak-Higashi syndrome: studies in 4 patients with a review of the literature. Medicine (Balrimore). 1972; 54: 247
   Google Scholar
• Blume R. S., Bennett J. M., Yankee R. A., Woiff S. M. Defective granulocytic regulation in the Chediak-Higashi syndrome. N. Engl. J. Med. 1968; 279: 1009
   Google Scholar
• Valenzuela R., Aikawa M., O'Regan S., Makker S. Chediak-Higashi syndrome in a black infant. Am J. Clin. Pathol. 1976; 65: 483
   Google Scholar
• Wolff S. M., Dale D. C., Clark R. A., Root R. K., Kimball H. R. The Chediak-Higashi syndrome: studies of host defenses. Ann. Intern. Med. 1972; 76: 293
   PubMed Web of Science ®Google Scholar
• Root R. K., Rosenthal A. S., Balestra D. J. Abnormal bactericidal, metabolic and lysosomal functions of Chediak-Higashi syndrome leukocytes. J. Clin. Invest. 1972; 51: 649
   PubMed Web of Science ®Google Scholar
• Kimball H. R., Ford G. H., Wolff S. M. Lysosomal enzymes in normal and Chediak-Higashi blood leukocytes. J. Lab. Clin. Med. 1975; 86: 616
   PubMed Web of Science ®Google Scholar
• Davis W. C., Douglas S. D. Defective granule formation and function in the Chediak-Higashi syndrome in man and animals. Semin. Hematol. 1972; 9: 431
   Google Scholar
• Rausch P. G., Pryzwansky K. B., Spitznagel J. K. Immunochemical identification of azurophilic and specific granule markers in the giant cell granules of Chediak-Higashi neutrophils. N. Engl. J. Med 1978; 298: 693
   PubMed Web of Science ®Google Scholar
• Zurier R. B. Prostaglandins and cyclic nucleotides in the Chediak-Higashi syndrome and experimental septic lupus erythematosus. J. Invest. Dermarol. 1978; 71: 36
   Google Scholar
• Boxer L. A., Watanabe A. M., Rister M., Besch H. R., Allen J., Baehner R. L. Correction of leukocyte function in Chediak-Higashi syndrome by ascorbate. N. Engl. J. Med. 1976; 295: 1041
   PubMed Web of Science ®Google Scholar
• Hartsock R. J. Post-vaccinial lymphadenitis: hyperplasia of lymphoid tissue that simulates malignant lymphomas. Cancer (Philadelphia) 1968; 21: 632
   PubMed Web of Science ®Google Scholar
• Patterson S. D., Larson E. B., Corey L. Atypical generalized zoster with lymphadenitis mimicking lymphoma. N. Engl. J. Med. 1980; 302: 848
   Google Scholar
• Salvador A. H., Harrison E. G., Kyle R. A. Lymphadenopathy due to infectious mononucleosis: its confusion with malignant lymphoma. Cancer (Philadelphia) 1971; 27: 1029
   Google Scholar
• Tindle B. H., Parker J. W., Lukes R. J. “Reed-Sternberg cells” in infectious mononucleosis?. Am. J. Clin. Pathol. 1972; 58: 607
   PubMed Web of Science ®Google Scholar
• Frizzera C., Moran E. M., Rappaport H. Angioimmunoblastic lymphadenopathy. Am. J. Med. 1975; 59: 803
   PubMed Web of Science ®Google Scholar
• Lukes R. J., Tindle B. H. Immunoblastic lymphadenopathy. N. Engl. J. Med. 1975; 292: 1
   PubMedGoogle Scholar
• Henle G., Henle W., Diehl V. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc. Natl. Acad. Sci. U.S.A. 1968; 59: 94
   PubMed Web of Science ®Google Scholar
• Niederman J. C., Evans A. S., Submhmanyan M. S., McCollum R. W. Prevalence, incidence, and persistence of EB virus antibody in young adults. N. Eng. J. Med. 1970; 382: 361
   Google Scholar
• Sutton R. N. The EB virus in relation to infectious mononucleosis. J. Clin. Pathol. 1972; 6: 58, (Suppl.)
   Google Scholar
• Neiderman J. C., Miller G., Pearson H. A., Pagano J. S., Dowaliby J. M. Infectious mononucleosis: Epstein-Barr virus shedding in saliva and the oral pharynx. N. Engl. J. Med. 1976; 294: 1355
   Google Scholar
• Epstein M. A., Achong B. G. Recent progress in Epstein-Barr virus research. Annu. Rev. Microbiol. 1977; 31: 421
   PubMed Web of Science ®Google Scholar
• Epstein M. A., Achong B. G. Pathogenisis of infectious mononucleosis. Lancet 1977; 2: 1270
   PubMed Web of Science ®Google Scholar
• Roechi G., de Felici A., Ragona G., Heinz A. Quantitative evaluation of Epstein-Barr-virusinfected mononuclear peripheral blood leukocytes in ifetiouss monounucleosis. N. Engl. J. Med. 1977; 296: 132
   Google Scholar
• Tosato G., Magrath I., Koski I., Dooley N., Blaese M. Activation of suppressor T-cells during Epstein-Barr-virus-induced ifectious mononucleosis. N. Engl. J. Med. 1979; 310: 1133
   Google Scholar
• Rapp C. E., Hewetson J. F. Infectious mononucleosis and the Epstein-Barr virus. Am. J. Dis. Child. 1978; 132: 78
   PubMedGoogle Scholar
• Ginsburg C. M., Henle W., Henle G., Horwitz C. A. Infectious mononucleousis in children. Evaluation of Epstein-Barr virus-specific serologic data. JAMA 1977; 237: 781
   PubMed Web of Science ®Google Scholar
• Chervenick P. A. Infectious mononucleosis. Dis. Mon. December, 1974; 5
   Google Scholar
• Horwitz C. A., Henle W., Henle G., Segal M., Arnold T., Lewis F. B., Zanick D., Ward P. C. J. Clinical and laboratory evaluation of elderly patients with heterophill antibody positive infectious mononucleosis. Am. J. Med. 1976; 61: 333
   PubMed Web of Science ®Google Scholar
• Lee C. L., Davidshon L., Panczyszyn O. Horse agglutinins in infectious mononucleosis. Am. J. Clin. Pathol. 1968; 49: 12
   PubMedGoogle Scholar
• Myhre B. A., Nakayama V. Serologic evaluation of the Mono-Chest test. Am. J. Clin. Pathol. 1976; 65: 987
   Google Scholar
• Horwitz C. A., Henle W., Henle G., Penn G., Hoffman N., Ward P. C. J. Persistently falsely positive tests for infectious mononucleosis. report of five cases with 4–6 year follow-up data. Am. J. Clin. Pathol. 1979; 72: 807
   PubMed Web of Science ®Google Scholar
• Henle W., Henle G. E., Horwitz C. A. Epstein-Barr virus specific diagnostic tests in infectious mononucleosis. Hum. Pathol. 1974; 5: 551
   PubMed Web of Science ®Google Scholar
• Andiman W. A., Miller G. Epstein-Barr virus. Manual of Clinicald Immunology, N. R. Rose, H. Friedman. American Society of Microbiology, Washington, D. C. 1976; 428
   Google Scholar
• Purtilo D. T., DeFlorio D., Hutt L. M., Bhawan J., Yang J. P. S., Otto R., Edwards W. Variable phenotypic expression of an X-linked recessive lymphoprolifertive syndrome. N. Engl. J. Med. 1977; 297: 1077
   PubMed Web of Science ®Google Scholar
• Nathwani B. N., Rappaport H., Moran E. M., Pangalis G. A., Kim H. Malignant lymphoma arising in angioimmunoblastic lymphadenopathy. Cancer (Philadelphia) 1978; 41: 578
   PubMed Web of Science ®Google Scholar
• Palutke M., Khilanani P., Weise R. Immunologic and electron microscopic characteristics of a case of immunoblastic lymphadenopathy. Am. J. Clin. Pathol. 1976; 65: 929
   PubMed Web of Science ®Google Scholar
• Neiman R. S., Dervan P., Haudenschild C., Jaffe R. Angioimmunoblastic lymphadenopathy. An ultrastructural and immunologic study with review of the literature. Cancer (Philadelphia) 1978; 41: 507
   PubMed Web of Science ®Google Scholar
• Pangalis G. A., Moran E. M., Rappaport H. Blood and bone marrow findings in angioimmunoblastic lymphadenopathy. Blood 1978; 51: 71
   PubMed Web of Science ®Google Scholar
• Matloff R. B., Neiman R. S. Angioimmunoblastic lymphadenopathy. A generalized lymphoproliferative disorder with cutaneous manifestations. Arch. Dermatol. 1978; 114: 92
   PubMed Web of Science ®Google Scholar
• Weisenburger D., Armitage J., Dick F. Immunoblastic lymphadenopathy with pulmonary infiltrates, hypocomplementemia and vasculitis. A hyperimmune syndrome. Am. J. Med. 1977; 63: 849
   PubMed Web of Science ®Google Scholar
• Kosrnidis P. A., Axelrod A. R., Palacas C., Stahl M. Angioimmunoblastic lymphadenopathy. A T-cell deficiency. Cancer (Philadelphia) 1978; 42: 447
   Google Scholar
• Rudders R. A., DeLellis R. Immunoblastic lymphadenopathy: a mixed proliferation of T and B lymphocytes. Am. J. Clin. Pathol. 1977; 68: 518
   PubMed Web of Science ®Google Scholar
• Gleichmann E., van Elven F., Gleichmann H. Immunoblastic lymphadenopathy, systemic lupus erythematosus and related disorders. Am. J. Clin. Pathol. 1979; 72: 708
   PubMed Web of Science ®Google Scholar
• Saltzstein S. L., Ackerman L. V. Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically and pathologically malignant lymphomas. Cancer (Philadelphia) 1959; 12: 164
   PubMed Web of Science ®Google Scholar
• Greene D. A. Localized cervical lymphadenopathy induced by diphenyl hydantoin sodium. Arch. Orolaryngol. 1975; 101: 446
   PubMed Web of Science ®Google Scholar
• Stanley J., Fallon-Pellici V. Phenytoin hypersensitivity reaction. Arch. Dermatol. 1978; 114: 1350
   Google Scholar
• Charlesworth E. N. Phenytoin-induced psuedolymphoma syndrome. Arch. Dermatol. 1977; 113: 477
   Google Scholar
• Halevy S., Feuerman E. J. Pseudolymphoma syndrome. Dermatologica 1977; 155: 321
   Google Scholar
• Gams R. A., Neal J. A., Conrad F. G. Hydantoin-induced-pseudolymphoma. Ann. Intern. Med. 1968; 69: 557
   PubMed Web of Science ®Google Scholar
• Li F. P., Willard D. R., Goodman R., Vawter G. Malignant lymphoma after diphenyl hydantion (dilantin) therapy. Cancer (Philadelphia). 1975; 36: 1359
   PubMed Web of Science ®Google Scholar
• Sorrell T. C., Forbes I. J., Burness F. R., Rischbieth R. H.C. Depression of immunological function in patientsd treated with phenytoin sodium(sodium diphenylhydantoin). Lancet 1971; 2: 1233
   PubMedGoogle Scholar
• Gershwin M. E., Steinberg A. D. Loss of suppressor function as a cause of lymphoid malignancy. Lancet 1973; 2: 1174
   PubMed Web of Science ®Google Scholar
• Kruger G., Harris D., Sussman E. Effect of dilantin in mice. II. Lymphoreticular tissue atypia and neoplasia after chronic exposure. Z. Krebsforsch 1972; 78: 290
   Google Scholar
• Kruger G. R. F., Harris D. Is phenytoin carciogenic?. Lancet 1972; I: 323
   Google Scholar
• Kawaski T., Kosaki F., Okawa S., Shigematsu I., Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLSN) prevailing in Japan. Pediatrics 1974; 54: 271
   Google Scholar
• Everett E. D. Mucocutaneous lymph node syndrome (Kawaski disease) in adults. JAMA 1979; 242: 542
   Google Scholar
• Yanagaihara R., Todd J. K. Acute febrile mucocutaneous lymph node syndrome. Am. J. Dis. Child. 1980; 134: 603
   Google Scholar
• Tanaka N., Sekimoto K., Naoe S. Kawaski disease relationship with infantile periaritis nodosa. Arch. Pathol. Lab. Med. 1976; 100: 81
   PubMed Web of Science ®Google Scholar
• Kahn G. Mucocutaneous lymph node syndrome. A new disease remaking its debut. Arch. Dermatol. 1978; 114: 948
   Google Scholar
• Fukushige J., Nihill M. R., McNamara D. G. Spectrum of cardiovascular lesions in muccoutaneous lymph node syndrome: analysis of 8 cases. Am. J. Cardiol. 1980; 45: 98
   Google Scholar
• Fujiwara S., Hamashima Y. Pathology of the heart in Kawaski disease. Pediatrics 1978; 61: 100
   PubMed Web of Science ®Google Scholar
• Kusakaw S., Heiner D. C. Elevated levelsd of immunoglobin E in the acute febrile mucocutaneous lymph node syndrome. Pediatre. Res. 1976; 10: 108
   Google Scholar
• Fossard C., Thompson R. A. Mucocutaneous lymph node syndrome (Kwaski disease): probable soluble-complex disorder. Br. Med. J. 1977; I: 883
   Google Scholar
• Gray G. F., Jr., Kimball A. C., Kean B. H. The posterior cervical lymph node in toxoplasmosis. Am. J. Pathol. 1972; 69: 349
   PubMed Web of Science ®Google Scholar
• Jacobs L. Toxoplasma and toxoplasmosis. Annu. Rev. Microbiol 1963; 17: 429
   Google Scholar
• Krick J. A., Remington J. S. Toxoplasmosis in the adult: an overview. N. Engl. J. Med. 1978; 298: 550
   PubMed Web of Science ®Google Scholar
• Dotolo J. R. Toxoplasmosis monunucleosis. R.I. Med. J. 1974; 57: 104
   Google Scholar
• Desmonts G., Couvrear J. Congenital toxoplasmosis. A prospective study of 378 pregnancies. N. Engl. J. Med. 1974; 290: 1110
   PubMed Web of Science ®Google Scholar
• Jacobs L. New knowledge of toxoplasma and toxoplasmosis. Adv. Parasitol. 1973; 11: 631
   PubMedGoogle Scholar
• Dorfman C. F., Remington J. S. Value of lymph node biopsy of acute acquired toxoplasmosis. N. Engl. J. Med. 1973; 289: 878
   PubMed Web of Science ®Google Scholar
• Lunder M. N. Laboratory methods in the diagnosis of toxoplasmosis. Health Lab. Sci. 1973; 10: 319
   Google Scholar
• Voller A., Bidwell D. E., Bartlet A., Fleck D. G., Perkins M., Oladehin B. A microplate enzyme immunoassay for toxoplasma antibody. J. Clin. Pathol. 1976; 29: 150
   PubMed Web of Science ®Google Scholar
• Walls K. W., Bullock S. L., English D. K. Use of the enzyme-linked immunosorbent assay (ELISA) and its microadaptation for the serodiagnosis of toxoplasmosis. J. Clin. Microbiol. 1977; 5: 273
   PubMed Web of Science ®Google Scholar